Skip to main content
SpringerLink
Log in

Angina Pectoris Prophylaxis: A Model Estimate of Cost and Benefit

  • Chapter
Costs and Benefits in Health Care and Prevention

  • 49 Accesses

Abstract

Nitroglycerin has been widely used for 100 years in preventing and relieving symptoms of angina pectoris. Angina pectoris results when the heart requires more oxygen than can be supplied by the coronary arterial system. The major symptom is chest discomfort. Nitroglycerin is a potent smooth muscle relaxer and vasodilator; it works to bring the demand and supply of oxygen to the heart into a more favorable balance, thus, relieving discomfort.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bundesausschuß der Ärzte und Krankenkassen (ed.) (1988): Preisvergleichsliste. Deutscher Ärzte-Verlag, Köln

    Google Scholar 

  2. Ciba-Geigy Ltd. (1984): White paper on transdermal nitroglycerin patch therapy for the prevention of angina pectoris. Basle

    Google Scholar 

  3. Dinkel, R. (1983): Ökonomische Analyse eines neuen Therapiekonzeptes: Nitroderm TTS. Swiss Pharma 10: 27–29

    Google Scholar 

  4. Dinkel, R. (1986): Die transdermale Therapie der Angina pectoris im Wirtschaftlichkeitstest. Österreichische Ärztezeitung 19: 54–56

    Google Scholar 

  5. Lauper, P. (1988): The socioeconomic study program on Nitroderm TTS. In: van Eimeren, W., Horisberger, B. (eds): Socioeconomic evaluation of drug therapy, 101–109. Springer Verlag, Berlin, Heidelberg, New York

    Chapter  Google Scholar 

  6. Oberender, P.O. (1988): Cost-benefit analysis of angina prophylaxis in the Federal Republic of German. In: van Eimeren, W., Horsberger, B.- (eds): Socioeconomic evaluation of drug therapy, 132–140. Srpinger Verlag, Berlin, Heidelberg, New York

    Chapter  Google Scholar 

Download references

Authors
  1. R. H. Dinkel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Sozialmedizin und öffentliches Gesundheitswesen (IDIS), Universität Bielefeld und institut für Dokumentation und Information, Westerfeldstr. 35-37, D-4800, Bielefeld, Federal Republic of Germany

    U. Laaser

  2. National Heart, Lung, and Blood Institute, National Institute of Health, Building 31, Room 4, 16C, 20892, Bethesda, Maryland, USA

    E. J. Roccella Ph. D.

  3. Belinson Medical Center, University of Tel Aviv, 49 100, Petah Tikva, Israel

    J. B. Rosenfeld

  4. Abteilung G-K, Boehringer Mannheim GmbH, Postfach 310120, D-6800, Mannheim 31, Federal Republic of Germany

    H. Wenzel

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dinkel, R.H. (1990). Angina Pectoris Prophylaxis: A Model Estimate of Cost and Benefit. In: Laaser, U., Roccella, E.J., Rosenfeld, J.B., Wenzel, H. (eds) Costs and Benefits in Health Care and Prevention. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75781-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-75781-5_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-52708-4

  • Online ISBN: 978-3-642-75781-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation